USPTO Proposes Revisions to Patent Trial and Appeal Board Practices
Published Date: 10/17/2025
Proposed Rule
Summary
The USPTO wants to change the rules for how patent challenges happen before the Patent Trial and Appeal Board. These updates affect inventors, companies, and lawyers by making the review process clearer and possibly faster. If you want to share your thoughts, you need to comment by November 17, 2025—so don’t wait!
Analyzed Economic Effects
6 provisions identified: 4 benefits, 2 costs, 0 mixed.
IPR Barred If Claims Were Already Found Valid
The PTAB would not institute or maintain an IPR for a challenged claim (or an independent claim from which it depends) if that claim was already found not invalid under 35 U.S.C. 102 or 103 by (1) a district court trial or jury verdict, (2) district court summary judgment, (3) the U.S. International Trade Commission, (4) a PTAB final written decision, (5) ex parte reexamination office action/Board decision, or (6) where the Federal Circuit reversed a finding of unpatentability or invalidity.
Must Promise Not To Re-raise Key Grounds
If you file an inter partes review (IPR) petition, the Board will not start or keep the IPR unless you file a written stipulation saying that, if a trial is instituted, you and any real party in interest will not raise invalidity or unpatentability grounds under 35 U.S.C. 102 or 103 in any other proceeding. That stipulation must be filed with the PTAB and any other tribunal where you are litigating regarding the challenged patent.
No IPR When Parallel Case Likely Decides First
The USPTO would not institute or maintain an IPR if, more likely than not, a parallel district court trial, an ITC initial/final determination, or a PTAB final written decision will occur with respect to the challenged claim before the PTAB's final written decision is due under 35 U.S.C. 316(a)(11).
Rule Aimed To Reduce Litigation Costs For Small Firms
The USPTO states the proposed rule focuses IPRs on patents not previously litigated or resolved early and estimates this will reduce litigation costs and transaction costs for patent licensing, likely benefiting a greater percentage of small entities. The Office certified the rule would not have a significant economic impact on a substantial number of small entities.
More PTAB Time For Ex Parte Appeals
The USPTO says limiting some IPRs will free administrative patent judge (APJ) time to handle ex parte appeals from examination, which the Office says should reduce ex parte appeal pendency and speed decisions on whether patent application claims should issue.
Paperwork Time Up 1 Hour Per Petition
The USPTO estimates each IPR petition will need one extra hour (from 120 to 121 hours) to prepare and submit the new stipulation. At 1,300 petitions per year, the Office estimates an added 1,300 annual respondent burden hours and an increase of $581,100 in hourly cost burden (using $447/hour).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-05564 — Required Use by Foreign Applicants and Patent Owners of a Patent Practitioner
Starting July 20, 2026, anyone outside the U.S. applying for or owning a U.S. patent must work with a registered patent expert. This change makes the U.S. match other countries, speeds up patent processing, and helps stop fraud. If you’re a foreign inventor or patent owner, get ready to team up with a pro to keep your patent game strong!
2026-05221 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission To Practice and Roster of Registered Patent Attorneys and Agents Admitted To Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on updating how they collect info about patent attorneys and agents who can practice before them. This affects patent pros who want to stay on the official roster and keep practicing. Comments are open until May 18, 2026, with no new fees, just a smoother info update process.
2026-04901 — Request for Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
The U.S. Patent and Trademark Office wants your thoughts on joining a new global treaty that makes it easier and faster to protect cool designs worldwide. If the U.S. signs on, designers could save time and money when applying for design protections both here and abroad. You’ve got until June 11, 2026, to share your ideas and help shape this decision!
2026-04987 — Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons
The USPTO just updated its rules to give designers more freedom when applying for patents on computer-generated interfaces and icons. This change affects anyone filing or already working on design patent applications related to digital images, starting March 13, 2026. It means you can now show your cool, original designs in new ways without extra hassle—no extra fees, just more creative control!
2026-04519 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Deposit of Biological Materials
The USPTO is asking for your thoughts on renewing a form that helps patent applicants deposit biological materials, like tiny living things, when applying for patents. This update won’t cost you money but aims to keep paperwork easy and clear. If you want to share your ideas, make sure to comment by April 8, 2026!
2026-04345 — Grant of Interim Extension of the Term of U.S. Patent No. 9,724,499; V-WAVE® Ventura® Interatrial Shunt System
The U.S. Patent Office just gave V-Wave Ltd. a one-year extra boost on their patent for the V-WAVE Ventura Interatrial Shunt System because the FDA review is still happening. This means V-Wave keeps exclusive rights to their medical device until March 11, 2027, giving them more time to market it without competition. It’s a win for innovation and business while the final FDA approval is still in progress!
Previous / Next Documents
Previous: 2025-19557 — Periodic Reporting
The Postal Service wants to change how it counts the costs of mail that can’t be delivered as addressed (UAA mail) in its regular reports. This affects anyone interested in postal costs and mail delivery, and the public can comment by November 3, 2025. These changes aim to make cost reports clearer and more accurate, but they won’t change your mailbox or prices right now.
Next: 2025-19587 — Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement
The USPTO is pulling back a proposed rule that would have changed how patent challenges are handled by the Patent Trial and Appeal Board. This affects inventors, companies, and lawyers who deal with patent reviews, as the changes around multiple petitions and settlements won’t happen now. No new fees or deadlines are coming from this, but stay tuned for future updates!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in